RENAL CANCER
Clinical trials for RENAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RENAL CANCER trials appear
Sign up with your email to follow new studies for RENAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail for advanced kidney cancer shows early promise, but trial halted
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: RENAL CANCER
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New pill shows promise in battling advanced kidney cancer
Disease control TerminatedThis trial tested an oral drug called NKT2152 in 120 people with advanced clear cell kidney cancer that had worsened after other treatments. The goal was to find the safest dose and see if it could shrink tumors. The study was stopped early, but results may help guide future trea…
Matched conditions: RENAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Cancer drug trial halted: AUR 109 shows mixed early results
Disease control TerminatedThis study tested three different doses of an experimental drug called AUR 109 in 29 adults with advanced colorectal, ovarian, or kidney cancer who had already tried at least two other treatments. The goal was to see if the drug could shrink tumors and to check its safety. Howeve…
Matched conditions: RENAL CANCER
Phase: PHASE2 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC